Julie H. Ostrander

Optical Redox Ratio Differentiates Breast Cancer Cell Lines Based on Estrogen Receptor Status

Julie H. Ostrander, Christine M. McMahon, Siya Lem et al. · Cancer Research · 2010 · 182 citations · Full text

Optical Redox Ratio, Breast Oncology, Oncologic Imaging +17

Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes

Andrea R. Daniel, Angela L. Gaviglio, Todd P. Knutson et al. · Oncogene · 2014 · 135 citations · Full text

Receptor-b Enhances, Breast Oncology, Hormonal Receptor +7

Breast Tumor Kinase (Protein Tyrosine Kinase 6) Regulates Heregulin-Induced Activation of ERK5 and p38 MAP Kinases in Breast Cancer Cells

Julie H. Ostrander, Andrea R. Daniel, Kristopher A. Lofgren et al. · Cancer Research · 2007 · 133 citations

Light Scattering Measurements of Subcellular Structure Provide Noninvasive Early Detection of Chemotherapy-Induced Apoptosis

Kevin J. Chalut, Julie H. Ostrander, Michael G. Giacomelli et al. · Cancer Research · 2009 · 87 citations · Full text

Nuclear Diameter, Tissue Imaging, Medicine +13

Linkage of progestin and epidermal growth factor signaling: Phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth

Andrea R. Daniel, Ming Qiu, Emily J. Faivre et al. · Steroids · 2006 · 86 citations · Full text

Breast Oncology, Progesterone Receptors, Endocrine-related Cancer +11